ArticleImmunologic research2026
FTO-mediated m6A demethylation of TRIM21 regulates macrophage polarization and attenuates myocardial ischemia-reperfusion injury.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myocardial infarction (MI) and ischemia-reperfusion injury (IRI) are critical challenges in clinical practice. The function of macrophage in this process has gained increasing attention. Macrophage polarization from pro-inflammatory (M1) to reparative (M2) phenotypes is crucial for cardiac repair. However, the regulatory mechanisms behind macrophage polarization, particularly involving m6A modification are not well understood. We utilized a mouse model of myocardial IRI to study m6A modifications and related enzymes in a mouse model of myocardial IRI. We co-cultured bone marrow-derived macrophages with conditioned medium from HL-1 cells to assess the role of FTO in macrophage polarization. Through bioinformatics analysis and m6A methylated RNA immunoprecipitation (MeRIP), TRIM21 was identified as a target gene of FTO. Finally, we investigated the effects of FTO and TRIM21 on myocardial injury in macrophages using transgenic mice. After IRI, FTO expression was reduced in cardiac macrophages, which was associated with enhanced m6A modification and a shift toward M1 polarization. Overexpression of FTO promotes M2 polarization, reduces inflammatory cytokine levels, and attenuates myocardial injury. In addition, TRIM21 knockdown inhibited activation of the NF-κB pathway, thereby suppressing M1 polarization. In vivo experiments using transgenic mice expressing FTO and TRIM21 specifically in macrophages demonstrated that FTO attenuated myocardial injury, whereas TRIM21 exacerbated myocardial injury through an opposite effect on macrophage polarization. These findings emphasize the critical roles of FTO and TRIM21 in macrophage-mediated myocardial repair and provide potential therapeutic targets for attenuating IRI.
Indexed as
Identifiers
42033549What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.